To address the national shortage of surgical oncology clinician-investigators, the Department of Surgical Oncology at the University of Texas M.D. Anderson Cancer Center has dedicated its T32 training program to producing academic surgical oncologists. This goal is being met by developing in our T32 trainees the research background skills necessary to be a productive surgical investigator. Moreover, we are committed to providing T32 training to groups that are underrepresented in academic surgical oncology, including minority individuals and women. Our T32 program provides research opportunities in a broad range of basic oncologic disciplines, including tumor biology, oncogene and tumor suppressor gene biology, signal transduction, cellular and molecular tumor immunology, gene transfer, angiogenesis, experimental therapeutics and other cancer-related research areas. In addition, we recently reincorporated the option for T32 fellows to obtain training in """"""""clinical effectiveness"""""""" while still obtaining didactic training in basic science research. This training broadens the education of all trainees through our conference structure. This versatility in academic training increases the likelihood of obtaining an academic position upon completion of training. Training in biostatistics and the responsible conduct of research, and a rich array of seminars and graduate courses are integral to this T32 program. ? ? Training is offered to postdoctoral M.D. fellows either during a 24-month hiatus from General Surgery residency or during a two to three-year fellowship in Surgical Oncology that begins after General Surgery residency. Upon completion of training almost all T32 trainees have either entered Surgical Oncology fellowships or geographic full-time academic Surgical Oncology positions. The T32 program faculty includes surgical investigators and full-time basic science researchers, the vast majority of whom have peer-reviewed grant support. The University of Texas M.D. Anderson Cancer Center vigorously promulgates a core mission of excellence in research, education, and patient care. As a result, this is a highly stimulating environment in which aspiring academic surgical oncologists can receive research training under the aegis of the T32 program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009599-19
Application #
7195812
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
1994-05-25
Project End
2008-01-31
Budget Start
2007-02-01
Budget End
2008-01-31
Support Year
19
Fiscal Year
2007
Total Cost
$372,397
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Keung, Emily Z; Tsai, Jen-Wei; Ali, Ali M et al. (2018) Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy. Oncoimmunology 7:e1385689
Keung, Emily Z; Chiang, Yi-Ju; Cormier, Janice N et al. (2018) Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer 124:4495-4503
Narula, Nisha; Kim, Bradford J; Davis, Catherine H et al. (2018) A proactive outreach intervention that decreases readmission after hepatectomy. Surgery 163:703-708
Cloyd, Jordan M; Mizuno, Takashi; Kawaguchi, Yoshikuni et al. (2018) Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies. Ann Surg :
Dood, Robert L; Fleming, Nicole D; Coleman, Robert L et al. (2018) When Ovarian Cancer Is Not: Characterizing Nonovarian Cancer Pathology in a Laparoscopy-Based Triage System. Int J Gynecol Cancer 28:1485-1490
Wang, Yinghong; Wiesnoski, Diana H; Helmink, Beth A et al. (2018) Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat Med 24:1804-1808
Kim, Bradford J; Soliz, Jose M; Aloia, Thomas A et al. (2018) What Is the Best Pain Control After Major Hepatopancreatobiliary Surgery? Adv Surg 52:235-246
Fonseca, Annabelle L; Kirkwood, Kimberly; Kim, Michael P et al. (2018) Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk. Pancreas 47:272-279
Lillemoe, Heather A; Aloia, Thomas A (2018) Enhanced Recovery After Surgery: Hepatobiliary. Surg Clin North Am 98:1251-1264
Ivanics, Tommy; Bergquist, John R; Liu, Gang et al. (2018) Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant type. Lab Invest 98:947-956

Showing the most recent 10 out of 202 publications